Press Releases & Presentations

 
(Swipe to view full table)
  Date Title and Summary View

Jun 7, 2017

Accelerate Diagnostics to Present at the 37th Annual Growth Stock Conference hosted by William Blair & Company
TUCSON, Ariz., June 07, 2017 (GLOBE NEWSWIRE) -- Lawrence Mehren, president and chief executive officer of Accelerate Diagnostics, will present at the 37th Annual Growth Stock Conference hosted by William Blair & Company in Chicago on Wednesday, June 14, 2017, at 04:00 PM Central Time. A live webcast of the presentation will be accessible fr...Read more

May 30, 2017

Accelerate Diagnostics announces sizeable release of data at ASM Microbe 2017
TUCSON, Ariz., May 30, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced that new data from 11 healthcare institutions covering more than 1,200 samples will be presented at the upcoming annual meeting of the American Society for Microbiology - ASM Microbe in New Orleans, LA. The data comes from external studies that evalu...Read more

May 15, 2017

Accelerate Diagnostics Announces Closing of $79.3 Million Upsized Offering
TUCSON, Ariz., May 15, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced the closing of its previously announced underwritten public offering of 2,750,000 shares of its common stock today, upsized from the original share offering of 2,500,000 shares of common stock, at a previously disclosed public offering price of $2...Read more

May 9, 2017

Accelerate Diagnostics Announces Pricing of Upsized Public Offering of Common Stock
TUCSON, Ariz., May 09, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced the pricing of an underwritten public offering of 2,750,000 shares of its common stock, upsized from the original share offering of 2,500,000 shares of common stock, at a price to the public of $28.85 per share. All of the shares are being s...Read more

May 8, 2017

Accelerate Diagnostics Announces Proposed Public Offering of Common Stock
TUCSON, Ariz., May 08, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX) today announced that it has commenced an underwritten public offering of 2,500,000 shares of its common stock. All of the shares are being offered by Accelerate Diagnostics. In addition, Accelerate Diagnostics expects to grant the underwriters of the offeri...Read more

May 3, 2017

Accelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017
TUCSON, Ariz., May 03, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary financial results for the quarter ending March 31, 2017 including signed customer evaluation contracts covering 169 instruments, 22 additional instruments converted into revenue generating placements, and revenue growth exceeding 325% of the sam...Read more

Apr 18, 2017

Accelerate Diagnostics Schedules Call to Review First Quarter 2017 Results for May 3rd
TUCSON, Ariz., April 18, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Wednesday, May 3rd, 2017 to discuss its first quarter 2017 financial results and commercial progress. President and Chief Executive Officer, Lawrence Mehren, joined by Steve Reichling, Chief Financial Officer, ...Read more

Mar 15, 2017

Accelerate Diagnostics Names Tom Brown to Board of Directors
TUCSON, Ariz., March 15, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the election of Tom Brown to the company's board of directors. His appointment is effective March 14, 2017. Brown's appointment adds over 30 years of medical diagnostics expertise to the company's board of directors. Beginning his career with the A...Read more

Feb 23, 2017

Accelerate Diagnostics Receives FDA Marketing Authorization for the Accelerate Pheno™ System and Accelerate PhenoTest™ BC Kit
TUCSON, Ariz., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Accelerate) today announced that the U.S. Food and Drug Administration has granted the de novo request to market the Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for identification and antibiotic susceptibility testing of pathogens directly fro...Read more

Feb 23, 2017

Accelerate Diagnostics to Report Preliminary Fourth Quarter and Full Year 2016 Results on February 27th
TUCSON, Ariz., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced it will report preliminary fourth-quarter and full year 2016 financial results on Monday, February 27th, 2017. President and Chief Executive Officer, Lawrence Mehren, joined by Steve Reichling, Chief Financial Officer, will host a conference call to...Read more
1
2
3
...
7
Next Last

= add release to Briefcase
NASDAQ: AXDX
$ 30.30
+0.75
(2.54%)
4:00 PM ET on Jun 22, 2017
Day High: 30.40
Day Low:  28.90
Volume:    435,013
Delayed ~20 min., by eSignal.

Want to receive investor-related news and updates?

Join our mailing list

Other updates